FAM66C and cancer: The risk signature of our study included 8 lncRNAs (CRNDE, LINC00844, FAM66C, TUBA3FP, SNHG8, HAR1A, LINC00641, and MYCNOS), and previous evidence has suggested that these lncRNAs are closely linked to the occurrence and development of cancer.